Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

World's first RSV vaccine: GSK wins USFDA nod for Arexvy in older adults

Ruchika Sharma4 May 2023 11:48 AM IST

Respiratory syncytial virus is a common contagious virus affecting the lungs and breathing passages.

GSK, Pfizer resolve patent lawsuit over RSV vaccines

Patent infringement: Amgen sues Novartis to block generic osteoporosis, bone cancer drugs

Ruchika Sharma3 May 2023 5:30 PM IST

Amgen said the proposed biosimilars infringe 21 patents covering Prolia and Xgeva.

USFDA nod to physiotherapy monitoring device Pheezee

Ruchika Sharma3 May 2023 4:30 PM IST

The device generates reports, for the first time in the field of physiotherapy, enabling patients to track their recovery.

Indoco Remedies CRO AnaCipher gets one Form 483 from USFDA

USFDA issues EIR for Indoco Remedies Goa facility

Ruchika Sharma3 May 2023 3:55 PM IST

Mumbai: Indoco Remedies Ltd. announced today the receipt of an Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI) status...

Boehringer Ingelheim Jascayd receives regulatory approval for progressive pulmonary fibrosis in China

Boehringer Ingelheim Spesolimab bags USFDA Breakthrough Therapy Designation for prevention of generalized pustular psoriasis flares

Ruchika Sharma3 May 2023 2:30 PM IST

Generalized pustular psoriasis is a rare and potentially life-threatening chronic neutrophilic skin disease characterized by flares of widespread...

Cipla arm gets zero Form 483 observations from USFDA for USA facility

Ruchika Sharma3 May 2023 12:30 PM IST

Mumbai: Cipla has recently announced that the US Food and Drug Administration has concluded inspection with zero Form 483 observations at the Fall...

Strides, Orbicular ink pact to develop range of nasal sprays

Ruchika Sharma3 May 2023 11:30 AM IST

The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m.

Laurus Labs bags USFDA nod for Paediatric ARV Oral Dispersible Film drug Dolutegravir in HIV/AIDS treatment

Ruchika Sharma2 May 2023 4:24 PM IST

Hyderabad: Laurus Labs Ltd., a R&D driven pharmaceutical & biotech manufacturing company in India, has announced the receipt of the US Food...

Gilead Sciences gets USFDA nod for new Biktarvy indication

Gilead Sciences, US square off in billion-dollar HIV drug patent trial

Ruchika Sharma2 May 2023 3:46 PM IST

The USFDA approved Gilead's Truvada for HIV prevention in 2012 and approved its related drug Descovy for the same purpose in 2019.

CDSCO Panel Denies Trial Waiver for Atropine, Asks Sun Pharma to Conduct Phase III Study

USFDA halts Sun Pharma trials on dermatological drug Deuruxolitinib

Ruchika Sharma2 May 2023 2:46 PM IST

The company said it would work closely with the FDA to address the agency's concerns, which the drugmaker expected to be communicated within the next...

Pfizer Sells ViiV Stake for USD 1.9 Billion, Shionogi Emerges Bigger Partner

Pfizer, Astellas Pharma' Xtandi combo therapy cuts risk of metastasis, death by 58 percent in prostate cancer

Ruchika Sharma2 May 2023 12:30 PM IST

XTANDI (enzalutamide) is an androgen receptor signaling inhibitor.

Stryker raises profit forecast on stronger demand for surgical devices

Ruchika Sharma2 May 2023 11:31 AM IST

United States: Medical technology company Stryker Corp on Monday raised its full-year profit forecast, citing stronger demand for the company's...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok